All In MedTech

FDA Clearance Tracker · P150005-S049

IntellaNav MiFi Open-Irrigated Ablation Catheter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 17, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 17, 2020

Approved

Time to decision

191 days

Received Oct 9, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150005-S049
Device name
IntellaNav MiFi Open-Irrigated Ablation Catheter
Applicant location
St Paul, MN
Received
Oct 9, 2019
Decided
Apr 17, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150005

Device type

Device class
Class III

Every decision under product code OAD

FDA's approval statement

As written in FDA's record.

Approval for the DirectSense RF feature in the Rhythmia HDx Mapping System Software Version 4.0 to be used in conjunction with the IntellaNav MiFi Open-Irrigated Ablation Catheter during cardiac ablation.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.